Fundraising FoxAria CV
St. Paul, US · Founded 2010 · Delaware corporation · 7 known investors
Find your way into Aria CV
Each arrow is one introduction. Sign up to fill in the first one.
159 people can intro you to Joshua
Ask Lucas Raskin to introduce you to Joshua Woolley
You →Lucas · together at NuPulseCV, Inc. →Joshua
74 people can intro you to Peter
Ask Jamie Chen to introduce you to Peter DeLange
You →Jamie · together at Excelen, Center For Bone and Joint Research and Education →Peter
Sign up to find every way you can get introduced to Aria CV
- Your email: who you already know at Aria CV, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Aria CV team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
JW
Joshua WoolleyExecutiveHe has experience in mechanical circulatory support and cardiac device development, with expertise in clinical translation and cross-functional collaboration among medical, engineering, and business teams.
RG
Ryan GladneyExecutive
GG
Gary GrahamExecutive
PD
Peter DeLangeExecutivePeter DeLange is a medical device executive with over 25 years of experience developing and commercializing Class II and Class III devices, including cardiovascular and implantable systems. He previously founded and sold Devicix, a medical device development firm, and held senior leadership roles in R&D, regulatory, and clinical operations for implantable device programs.
BA
Bruce A. MachmeierExecutive
KV
Karl VollmersNamed on SEC filing
JS
John ScandurraNamed on SEC filing
JG
John GainorNamed on SEC filing
Board
DZ
RM
Renee MasiBoard director
GF
George FazioBoard director
Investors · 7
Angel Physicians Fundlisted by Angel Physicians Fund
How we know: Angel Physicians Fund's portfolio page · Not right? Tell us
Brightstone Venture Capitallisted by Brightstone Venture CapitalMinneapolis · $250K – $10M
How we know: Brightstone Venture Capital's portfolio page · Not right? Tell us
Broadview Ventureslisted by Broadview VenturesBoston
How we know: Broadview Ventures's portfolio page · a partner's Signal profile · Not right? Tell us
Catalyst Health Ventureslisted by Catalyst Health VenturesBoston · $1M – $3M
How we know: Catalyst Health Ventures's portfolio page · funding news · Not right? Tell us
Portfolialisted by PortfoliaSan Mateo · $10K
How we know: the VCSheet dataset · Not right? Tell us
Xeraya Capitallisted by Xeraya CapitalKuala Lumpur
How we know: Xeraya Capital's portfolio page · funding news · Not right? Tell us
BioStar VenturesreportedPetoskey
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$13.9M disclosed across 5 of 6 rounds · 2014–2025
▶$1.4MraisedAug 2025 · 39 investors · Other Health CareRule 506(b)
▶$1.4MraisedAug 2025 · 39 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Scott WardDirector
- Steven YakubovDirector
- Dan W. GladneyExecutive Officer, Director
- George FazioDirector
- Darshana ZaveriDirector
- Renee MasiDirector
- Karl VollmersExecutive Officer
- John ScandurraExecutive Officer
- Peter DeLangeExecutive Officer
- Offering amount
- $6M
- Amount sold
- $1.4M
- Sales commissions
- $136.6K
- Proceeds to insiders
- $1M
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.2MraisedSep 2024 · 33 investors · Other Health CareRule 506(b)
▶$2.2MraisedSep 2024 · 33 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Karl VollmersExecutive Officer
- John ScandurraExecutive Officer
- Joshua WoolleyExecutive Officer
- Ryan GladneyExecutive Officer
- Darshana ZaveriDirector
- Steven Yakubov, MDDirector
- Renee MasiDirector
- Maria Berkman, MDDirector
- George FazioDirector
- Gary GrahamExecutive Officer
- Dan W. GladneyExecutive Officer, Director
- Peter DeLangeExecutive Officer
- Jason RushtonDirector
- Offering amount
- $20M
- Amount sold
- $2.2M
- Sales commissions
- $266.3K
- Proceeds to insiders
- $1.9M
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.8MraisedJul 2022 · 23 investors · Other Health CareRule 506(b)
▶$7.8MraisedJul 2022 · 23 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Spencer KuboExecutive Officer
- Renee MasiDirector
- George FazioDirector
- John ScandurraExecutive Officer
- Peter DeLangeExecutive Officer
- Jason RushtonDirector
- Darshana ZaveriDirector
- Maria BeckmanDirector
- Dan W. GladneyExecutive Officer, Director
- Gary GrahamExecutive Officer
- Offering amount
- $13M
- Amount sold
- $7.8M
- Sales commissions
- $139.8K
- Proceeds to insiders
- $1.9M
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$666.6KraisedJan 2020 · 10 investors · Other Health CareRule 506(b)
▶$666.6KraisedJan 2020 · 10 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Renee MasiDirector
- John ScandurraExecutive Officer
- Richard SchroederExecutive Officer
- Darshana ZaveriDirector
- Maria BeckmanDirector
- Marc KnutsonExecutive Officer
- Dan W. GladneyExecutive Officer, Director
- Karl VollmersExecutive Officer
- Offering amount
- $18M
- Amount sold
- $666.6K
- Sales commissions
- $300K
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.9MraisedMar 2018 · 8 investors · BiotechnologyRule 506(b)
▶$1.9MraisedMar 2018 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Renee MasiDirector
- Darshana ZaveriDirector
- John ScandurraExecutive Officer, Director
- Dan W. GladneyDirector
- Karl VollmersExecutive Officer
- John GainorExecutive Officer
- Offering amount
- $5M
- Amount sold
- $1.9M
- Minimum investment
- $100K
- Sales commissions
- $75K
- Proceeds to insiders
- $60K
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Mar 2018
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.3MofferedDec 2014 · BiotechnologyRule 506(b)
▶$6.3MofferedDec 2014 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bruce A. MachmeierExecutive Officer
- Robert F. WilsonDirector
- John ScandurraExecutive Officer, Director
- Norman DannDirector
- Dan W. GladneyDirector
- Karl VollmersExecutive Officer
- Offering amount
- $6.3M
- Minimum investment
- $75K
- Sales commissions
- $127.5K
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Dec 2014
- Incorporated
- Corporation, Delaware, 2010
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
OsfhealthcareOSF HealthCare is an integrated health system operating 16 hospitals, urgent care clinics, primary and specialty care facilities, and digital health services across Illinois and Michigan. The organization serves patients through inpatient care, outpatient clinics, home health services, and virtual care platforms.
Rf SurgicalMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Companies working in the same space as Aria CV.
In the news
Frequently asked questions
- Who are Aria CV's investors?
- Aria CV's investors include Angel Physicians Fund, Brightstone Venture Capital, Broadview Ventures, Catalyst Health Ventures, Portfolia, Xeraya Capital, BioStar Ventures.
- How much funding has Aria CV raised?
- Aria CV has disclosed $13.9M raised across 5 of its 6 known rounds.
- Where is Aria CV headquartered?
- Aria CV is headquartered in St. Paul, US.